<DOC>
	<DOCNO>NCT02225223</DOCNO>
	<brief_summary>The purpose study evaluate treat painful metastatic lesion vertebral body pathologic fracture target radiofrequency ablation ( t-RFA ) vertebral augmentation ( VA ) prior follow radiation therapy .</brief_summary>
	<brief_title>Evaluation t-RFA RF-TVA Prior to/Following Radiation Therapy Treat Painful Metastatic Vertebral Body Tumor ( )</brief_title>
	<detailed_description>Prospective , multi-center clinical study . Stratification scheme : 'Failed/Refused Further RT ' `` No Previous RT ''</detailed_description>
	<criteria>1 . Male female patient ≥ 18 year old , 2 . One two painful vertebra ( T1L5 ) evidence osteolytic mixed lytic blastic metastatic lesion cross sectional imaging pathologic fracture ( presence nonpainful vertebrae metastatic lesion addition painful index vertebra allow ) 3 . Never receive radiation therapy index level ( ) ( follow consult radiation oncologist : conventional treatment option ) OR Received radiation therapy without adequate relief metastatic bone pain determine patient treat physician , treat physician would prescribe additional radiation treatment , refuse additional radiation therapy , 4 . Brief Pain Inventory ( BPI ) bad pain score ≥ 4 ( irrespective medication ) , 5 . Woman potential childbearing age agree medically effective birth control method , 6 . Life expectancy ≥ 2 month , 7 . Sufficient mental capacity comply protocol requirement , 8 . Understands potential risk benefit study participation willing provide write informed consent . 1 . Primary tumor bone ( e.g. , osteosarcoma ) site index vertebra ( e ) , 2 . Benign tumor bone ( e.g . osteoid osteoma ) site index vertebra ( e ) , 3 . Lesions due hematologic malignancy ( e.g . multiple myeloma site index vertebra ( e ) , 4 . Compromise posterior column vertebral body wall pedicles . 5 . Extraosseous extension metastatic lesion &gt; 10mm , 6 . Nonreversible uncorrectable coagulopathy . INR &gt; 1.5 , 7 . Platelet count &lt; 50,000 , 8 . Radiation therapy complete index vertebra ( e ) ≤ 28 day enrollment , 9 . Change chemotherapy agent plan 7 day enrollment ( change dose ( ) permit ) , 10 . Index vertebra ( e ) previous spine surgery include vertebroplasty kyphoplasty , 11 . Additional nonkyphoplasty/vertebroplasty surgical treatment require index vertebra ( e ) , 12 . Spinal cord compression canal compromise require decompression , 13 . Major surgery spine region index vertebra ( e ) perform within 3 month enrollment , 14 . Major elective surgery spine region index vertebra ( e ) plan within 1 month follow ablation cement procedure , 15 . Requires upper low limb surgery affect functional outcome , 16 . Significant clinical morbidity ( aside index vertebra ( e ) recurrent cancer ) may interfere data collection affect pain functional result , 17 . Medical/surgical condition contrary kyphoplasty procedure ( e.g. , presence active incompletely treated local infection , severe pulmonary insufficiency ) , 18 . Bedridden due paralysis neurological decline , 19 . Currently pregnant nursing , plan pregnancy ( period 6 month ) follow index procedure ( ) , 20 . Known allergy bone cement , 21 . Has heart pacemaker electronic device implant 22 . Concurrent participation participation within last 30 day prior enrollment clinical trial investigational medicinal drug/chemotherapeutic biologic medical product .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>metastatic lesion</keyword>
	<keyword>vertebral body</keyword>
	<keyword>ablation</keyword>
	<keyword>radiation</keyword>
	<keyword>target radio-frequency ablation</keyword>
	<keyword>radio-frequency target vertebral augmentation</keyword>
	<keyword>radiofrequency kyphoplasty</keyword>
	<keyword>spine</keyword>
	<keyword>vertebral augmentation</keyword>
	<keyword>kyphoplasty</keyword>
	<keyword>spinal ablation</keyword>
	<keyword>pain</keyword>
	<keyword>quality life</keyword>
	<keyword>spinal tumor</keyword>
</DOC>